Home / Internal Medicine
Internal Medicine
| 7 min read
Men have long lacked reversible contraceptives, but new hormonal and non-hormonal methods in development could finally give them control over family planning.
| 5 min read
Computational models are reshaping how therapies are discovered, tested, and optimized.
| 5 min read
Regulatory science is increasingly relying on modeling, simulation, and AI tools to accelerate drug development while maintaining safety and efficacy.
| 5 min read
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
| 2 min read
A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.
| 2 min read
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model.
| 2 min read
First DPP1 inhibitor drug milestone marks a long-awaited breakthrough for NCFB patients.
| 4 min read
For rare and inherited kidney diseases, genetic testing is solving the clinical trial recruitment crisis and reshaping how precision therapies get to patients.
| 2 min read
The new DMF gives developers a faster, simpler path to advance their cell therapy programs using trusted, clinical-grade starting materials.
| 3 min read
Insilico’s Phase 2a trial of an AI-designed therapy marks a milestone in data-driven drug development.
| 3 min read
Point-of-care tests that detect biomarkers from menstrual blood can enable broader access to disease monitoring and diagnosis.
| 2 min read
Expanded high-value end-to-end solution positions business for rapid growth in multi-billion dollar functional GI market
